시장보고서
상품코드
1477141

전립선 생검 시장 : 유형별, 검사 유형별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 전망(2024-2032년)

Prostate Biopsy Market, By Type, By Test Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 301 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

전립선 생검 시장 규모는 2023년 69억 1,843만 달러로 평가되었고, 2024년부터 2032년까지 연평균 복합 성장률(CAGR) 14.92%로 확대될 것으로 예상됩니다.

전립선 생검 시장 - 시장 역학

전립선암 발병률 증가가 시장 성장을 가속할 것으로 예상됩니다.

전립선암은 전 세계적으로 남성에게 흔한 암으로, 고령화와 진단 기술의 발달로 인해 전립선암의 진단이 증가하는 추세입니다. 전립선암 발병률이 증가함에 따라 전립선 생검과 같은 진단 절차의 필요성이 증가하고 있으며, PSA 검사와 같은 선별 검사를 받는 사람이 증가함에 따라 이상을 조기에 발견하여 생검을 통한 추가 진단 평가의 필요성이 증가하고 있습니다. 미국임상종양학회에 따르면 전립선암은 피부암을 제외하고 남성에게 가장 흔한 암 중 하나이며, 2023년에는 미국에서 약 288,300명의 남성이 전립선암 진단을 받을 것으로 추산됩니다. 전 세계적으로 2020년에 약 1,414,259명이 전립선암 진단을 받았습니다. 또한, 영상 기술의 발전과 의료비 증가는 시장에 성장 기회를 제공합니다. 하지만 의료기기 및 진단 절차에 대한 엄격한 규제 요건은 시장에 도전이 될 수 있습니다.

전립선 생검 시장 - 주요 인사이트

리서치 애널리스트의 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 14.92%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

유형별 세분화에서는 전립선 바늘 생검이 2023년 가장 큰 시장 점유율을 보일 것으로 예측됩니다.

검사 유형별로는 2023년 바이오마커 검사가 주요 검사 유형으로 부상할 것으로 예상됩니다.

지역별로는 북미가 2023년에 가장 큰 수익을 창출할 주요 시장입니다.

전립선 생검 시장 - 세분화 분석 :

세계 전립선 생검 시장은 유형, 검사 유형, 최종 사용자 및 지역을 기준으로 세분화됩니다.

시장은 유형에 따라 전립선 바늘 생검과 전립선 액상 생검의 두 가지로 나뉩니다. 전립선 바늘 생검이 시장의 대부분을 차지하고 있습니다. 전립선 생검 시장, 특히 전립선 바늘 생검 전문 분야는 기술 발전, 최소 침습 기술에 대한 관심 증가, 전립선암 검진에 대한 인식 증가로 인해 지속적으로 성장하고 있습니다.

시장은 검사 유형에 따라 면역조직화학, 생검, 바이오마커 검사, 영상검사, 기타 등 세 가지 범주로 나뉩니다. 바이오마커 검사는 시장을 선도하는 카테고리입니다. 이러한 검사는 전립선 생검 시장에서 필수적인 역할을 하고 있으며, 더 나은 위험 평가를 제공하고, 생검 선택에 도움을 주며, 전립선암 환자에게 맞춤형 치료 옵션을 제공합니다.

시장은 최종 사용자에 따라 암 연구 기관, 진단 실험실, 병원 및 기타 사업체의 세 가지 범주로 나뉩니다. 각 최종 사용자 부문은 전립선암의 진단, 치료 및 연구에 고유한 기여를 하고 있습니다.

전립선 생검 시장 - 지리적 통찰력

이 시장은 지리적으로 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 이 지역들은 사업 활동을 하는 국가에 따라 더 세분화됩니다. 북미는 첨단 생검 기기의 존재와 지속적인 기술 발전으로 인해 시장을 지배하고 있습니다. 북미는 잘 구축된 의료 인프라와 강력한 의료기기 산업의 혜택을 누리고 있습니다. 첨단 의료 기술 협회에 따르면 미국은 전 세계 의료 기술 시장의 40% 이상을 차지하며 가장 큰 점유율을 차지하고 있습니다. 또한 북미는 의료 연구, 혁신 및 기술 개발의 중심지 역할을 하고 있습니다. 또한 유럽은 시장 성장에서 두 번째로 큰 지역을 차지하고 있는데, 이는 주로 국민들의 질병에 대한 인식이 높기 때문입니다.

전립선 생검 시장 - 경쟁 구도 :

전립선 생검 시장의 경쟁 환경에서 생검 기기 및 기기 개발 및 제조에 주력하는 기업들은 생검의 정확성, 안전성 및 환자 복지를 향상시킬 수 있는 혁신적인 기술을 제공하기 위해 치열한 경쟁을 벌이고 있습니다. 마찬가지로 분자진단 및 바이오마커 검사 전문 기업들은 기존 생검법을 보완하는 검사를 제공하여 전립선암의 공격성과 치료 반응에 대한 더 많은 통찰력을 제공합니다. 제품을 차별화하고, 탄탄한 파트너십을 구축하며, 임상적 유효성을 입증할 수 있는 기업만이 이 어려운 환경에서 성공을 거둘 수 있습니다.

목차

제1장 전립선 생검 시장 개요

  • 조사 범위
  • 시장 추정 년도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 전립선 생검 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 향후 동향

제4장 전립선 생검 산업 연구

  • PEST 분석
  • Porter의 Five Forces 분석
  • 성장 전망 매핑
  • 규제 구조 분석

제5장 전립선 생검 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 전립선 생검 시장 구도

  • 전립선 생검 시장 점유율 분석, 2023년
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신규 기업 분석

제7장 전립선 생검 시장 - 유형별

  • 개요
    • 유형별 부문 점유율 분석
    • 전립선 침생검
    • 전립선 액체생검

제8장 전립선 생검 시장 - 검사 유형별

  • 개요
    • 검사 유형별 부문 점유율 분석
    • 면역조직화학
    • 생검
    • 바이오마커 검사
    • 영상 검사
    • 기타

제9장 전립선 생검 시장 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 암 연구기관
    • 진단 실험실
    • 병원
    • 기타

제10장 전립선 생검 시장 - 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 전립선 생검 업계

  • 경쟁 대시보드
  • 기업 개요
    • Thermo Fisher Scientific Inc.
    • CR Bard Inc.
    • STERIS LAB Srl
    • Boston Scientific Corporation
    • Cook
    • BIOBOT SURGICAL PTE LTD
    • D Biopsy Inc.
    • Eigen
    • Koninklijke Philips NV
    • Guardant Health Inc.
    • PURE Medical Device SA
    • Dickinson and Co.
    • F. Hoffmann-La Roche Ltd.
    • SOMATEX Medical Technologies GmbH
    • Others

제12장 애널리스트의 전방위 전망

LSH 24.05.28

REPORT HIGHLIGHT

Prostate Biopsy Market size was valued at USD 6,918.43 million in 2023, expanding at a CAGR of 14.92% from 2024 to 2032.

A prostate biopsy involves the extraction of small tissue samples from the prostate gland by a doctor to conduct cancer testing. This form of cancer is highly prevalent, with an estimated 174,000 men expected to receive a diagnosis this year, and approximately 31,000 of them succumbing to the disease. However, for the majority of men, prostate cancer either poses no issues or can be easily treated. It is important to note that a definitive diagnosis of prostate cancer cannot be made without undergoing a biopsy. Typically, a prostate biopsy is recommended if abnormalities are detected during routine screening tests, such as elevated levels of prostate-specific antigen (PSA) in the blood or abnormal findings during a digital rectal examination (DRE).

Prostate Biopsy Market- Market Dynamics

The growing incidence of prostate cancer is expected to propel the market growth

Prostate cancer is a prevalent cancer among men globally, with its diagnosis on the rise due to aging populations and improved diagnostic techniques. The increasing incidence of prostate cancer has led to a greater need for diagnostic procedures such as prostate biopsies. As more individuals undergo screening tests like PSA testing, abnormalities are identified earlier, leading to the necessity for further diagnostic assessments through biopsies. According to the American Society of Clinical Oncology, prostate cancer is among most common cancer in men, excluding skin cancer. It is estimated that in 2023, around 288,300 men in the United States will receive a prostate cancer diagnosis. Globally, approximately 1,414,259 individuals were diagnosed with prostate cancer in 2020. Moreover, advancements in imaging technologies and rising healthcare expenditure present growth opportunities for the market. Nevertheless, stringent regulatory requirements for medical devices and diagnostic procedures may present challenges for the market.

Prostate Biopsy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.92% over the forecast period (2024-2032)

Based on Type segmentation, Prostate Needle Biopsy was predicted to show maximum market share in the year 2023

Based on Test Type segmentation, Biomarker Tests were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Prostate Biopsy Market- Segmentation Analysis:

The Global Prostate Biopsy Market is segmented based on Type, Test Type, End-User, and Region.

The market is segmented into two categories according to Type: Prostate Needle Biopsy and Prostate Liquid Biopsy. Prostate Needle Biopsy holds the majority share in the market. The market for prostate biopsies, specifically the sector dedicated to prostate needle biopsies, is experiencing consistent growth due to technological progress, rising interest in minimally invasive techniques, and heightened awareness of prostate cancer screening.

The market is segmented into three categories according to Test Type: Immunohistochemistry, Biopsy, Biomarker Tests, Imaging Tests, and Others. Biomarker Tests are the leading category in the market. These tests have become essential in the prostate biopsy market, providing better risk assessment, assisting in biopsy choices, and facilitating tailored treatment options for prostate cancer patients.

The market is segmented into three categories according to End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, and other entities. Each segment of end-users contributes uniquely to the diagnosis, treatment, and study of prostate cancer.

Prostate Biopsy Market- Geographical Insights

This market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The North American region dominates the market due to the presence of advanced biopsy devices and continuous technological advancements. North America benefits from a well-established healthcare infrastructure and a strong medical device industry. According to the Advanced Medical Technology Association, the United States holds the largest share of the global medtech market, accounting for over 40% of it. Additionally, North America serves as a center for medical research, innovation, and technological development. Furthermore, Europe holds the second-largest region for market growth, primarily due to the high level of disease awareness among the population.

Prostate Biopsy Market- Competitive Landscape:

In the competitive landscape of the Prostate Biopsy Market, companies focused on developing and producing biopsy devices and instruments are in intense competition to bring forth innovative technologies that enhance biopsy precision, safety, and patient well-being. Similarly, companies specializing in molecular diagnostics and biomarker testing are providing tests that supplement conventional biopsy methods, offering further insights into the aggressiveness of prostate cancer and the response to treatment. Those companies that can distinguish their products, forge robust partnerships, and showcase clinical effectiveness are well-positioned to thrive in this challenging environment.

Recent Developments:

Thermo Fisher Scientific has recently unveiled more than 50 novel Absolute Q Liquid Biopsy Assays that can be utilized on the Applied Biosystems QuantStudio Absolute Q dPCR System*. This advanced digital PCR (dPCR) system is fully integrated and has been specifically designed to deliver remarkably precise and consistent results in just 90 minutes, requiring minimal manual intervention.

In an exciting development, Thermo Fisher Scientific has also announced a collaboration with Bayer to develop companion diagnostic assays for the drugmaker's cutting-edge precision cancer therapies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PROSTATE BIOPSY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific Inc.

C. R. Bard Inc.

STERIS LAB S.r.l

Boston Scientific Corporation

Cook

BIOBOT SURGICAL PTE LTD

3D Biopsy Inc.

Eigen

Koninklijke Philips N.V.

Guardant Health Inc.

PURE Medical Device SA

Dickinson and Co.

F. Hoffmann-La Roche Ltd.

SOMATEX Medical Technologies GmbH

Others

GLOBAL PROSTATE BIOPSY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Prostate Needle Biopsy
  • Prostate Liquid Biopsy

GLOBAL PROSTATE BIOPSY MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Immunohistochemistry
  • Biopsy
  • Biomarker Tests
  • Imaging Tests
  • Others

GLOBAL PROSTATE BIOPSY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Cancer Research Institutes
  • Diagnostic Laboratories
  • Hospitals
  • Others

GLOBAL PROSTATE BIOPSY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Prostate Biopsy Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Prostate Biopsy Market Snippet by Type
    • 2.1.2.Prostate Biopsy Market Snippet by Test Type
    • 2.1.3.Prostate Biopsy Market Snippet by End-User
    • 2.1.4.Prostate Biopsy Market Snippet by Country
    • 2.1.5.Prostate Biopsy Market Snippet by Region
  • 2.2.Competitive Insights

3.Prostate Biopsy Key Market Trends

  • 3.1.Prostate Biopsy Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Prostate Biopsy Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Prostate Biopsy Market Opportunities
  • 3.4.Prostate Biopsy Market Future Trends

4.Prostate Biopsy Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Prostate Biopsy Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Prostate Biopsy Market Landscape

  • 6.1.Prostate Biopsy Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Prostate Biopsy Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Prostate Needle Biopsy
    • 7.1.3.Prostate Liquid Biopsy

8.Prostate Biopsy Market - By Test Type

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 8.1.2.Immunohistochemistry
    • 8.1.3.Biopsy
    • 8.1.4.Biomarker Tests
    • 8.1.5.Imaging Tests
    • 8.1.6.Others

9.Prostate Biopsy Market - By End-User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2.Cancer Research Institutes
    • 9.1.3.Diagnostic Laboratories
    • 9.1.4.Hospitals
    • 9.1.5.Others

10.Prostate Biopsy Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Prostate Biopsy Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Prostate Biopsy Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Prostate Biopsy Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Prostate Biopsy Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Prostate Biopsy Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Prostate Biopsy Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Thermo Fisher Scientific Inc.
    • 11.2.2.C. R. Bard Inc.
    • 11.2.3.STERIS LAB S.r.l
    • 11.2.4.Boston Scientific Corporation
    • 11.2.5.Cook
    • 11.2.6.BIOBOT SURGICAL PTE LTD
    • 11.2.7.3D Biopsy Inc.
    • 11.2.8.Eigen
    • 11.2.9.Koninklijke Philips N.V.
    • 11.2.10.Guardant Health Inc.
    • 11.2.11.PURE Medical Device SA
    • 11.2.12.Dickinson and Co.
    • 11.2.13.F. Hoffmann-La Roche Ltd.
    • 11.2.14.SOMATEX Medical Technologies GmbH
    • 11.2.15.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제